Buyback Radar

Zimmer Biomet › Financials

Zimmer Biomet financials

ZBH

Ten years from Zimmer Biomet’s own SEC filings. Fiscal years end in December.

$18.12BMarket capat $94.98 a share
$8.51BRevenuelast 12 months to Jun 2026
$806.7MNet incomelast 12 months to Jun 2026
$1.52BFree cash flowlast 12 months to Jun 2026
$410.0MCashJun 2026
$7.48BDebtJun 2026

Income statement

Dec 2016fiscal yearDec 2017fiscal yearDec 2018fiscal yearDec 2019fiscal yearDec 2020fiscal yearDec 2021fiscal yearDec 2022fiscal yearDec 2023fiscal yearDec 2024fiscal yearDec 2025fiscal yearLast 12 monthsto Jun 2026Latest quarterJun 2026
Revenue$7.67B$7.80B$7.93B$7.98B$6.13B$6.83B$6.94B$7.39B$7.68B$8.23B$8.51B—
Operating income$821.1M$799.3M$33.8M$1.14B$83.1M$860.3M$696.3M$1.28B$1.29B$1.10B$1.21B—
Net income$305.9M$1.81B−$379.2M$1.13B−$138.9M$401.6M$231.4M$1.02B$903.8M$705.1M$806.7M—
Earnings per share, diluted$1.51$8.90−$1.86$5.47−$0.67$1.91$1.10$4.88$4.43$3.55——

Balance sheet

Dec 2016fiscal yearDec 2017fiscal yearDec 2018fiscal yearDec 2019fiscal yearDec 2020fiscal yearDec 2021fiscal yearDec 2022fiscal yearDec 2023fiscal yearDec 2024fiscal yearDec 2025fiscal yearLast 12 monthsto Jun 2026Latest quarterJun 2026
Cash and equivalents$634.1M$524.4M$542.8M$617.9M$802.1M$478.5M$375.7M$415.8M$525.5M$591.9M—$410.0M
Total assets$26.68B$25.96B$24.13B$24.64B$24.42B$23.46B$21.07B$21.50B$21.37B$23.09B—$22.80B
Debt$11.24B$10.14B$8.94B$8.20B$8.10B$1.00B$5.70B$5.80B$6.20B$7.52B—$7.48B
Total liabilities$17.01B$14.23B$12.85B$12.25B$12.22B$10.79B$9.04B$9.01B$8.89B$10.39B—$10.17B
Shareholders' equity$9.67B$11.74B$11.27B$12.39B$12.19B$12.66B$12.02B$12.48B$12.47B$12.70B—$12.62B

Cash flow

Dec 2016fiscal yearDec 2017fiscal yearDec 2018fiscal yearDec 2019fiscal yearDec 2020fiscal yearDec 2021fiscal yearDec 2022fiscal yearDec 2023fiscal yearDec 2024fiscal yearDec 2025fiscal yearLast 12 monthsto Jun 2026Latest quarterJun 2026
Operating cash flow$1.63B$1.58B$1.75B$1.59B$1.20B$1.50B$1.36B$1.58B$1.50B$1.70B$1.74B—
Capital spending$184.7M$156.0M$162.7M$207.1M$111.9M$143.6M$187.9M$291.1M$203.8M$224.5M$220.3M—
Free cash flow$1.45B$1.43B$1.58B$1.38B$1.09B$1.36B$1.17B$1.29B$1.30B$1.47B$1.52B—
Buybacks$415.5M—————$126.4M$692.2M$868.0M$487.0M$750.8M—
Dividends$188.4M$193.6M$195.2M$196.7M$198.5M$200.1M$201.2M$200.9M$196.0M$190.3M$188.4M—
Returned to shareholders$603.9M$193.6M$195.2M$196.7M$198.5M$200.1M$327.6M$893.1M$1.06B$677.3M$939.2M—
Stock-based pay$57.3M$53.7M$65.5M$84.3M$73.8M$76.0M$105.0M$99.8M$101.0M$90.2M$98.2M—
Where these numbers come from

Every column links to the filing it comes from on EDGAR. Last 12 months adds the latest year to date to the last 10-K and takes away the same months a year earlier. Debt is long-term debt including the part due within a year. A dash means the company did not report that line in a form we can read, never a zero. Market cap uses the latest closing price and the share count from the cover of the latest filing. How we count

Zimmer Biomet financials, answered

What is Zimmer Biomet's market cap?

$18.12B at $94.98 a share, with 190,737,689 shares outstanding as of Jul 30, 2026, from the cover of its latest SEC filing.

How much does Zimmer Biomet earn?

Revenue of $8.51B and net income of $806.7M in the last 12 months to Jun 2026.

How much debt does Zimmer Biomet have?

Zimmer Biomet reported $7.48B of debt and $410.0M of cash and equivalents on its balance sheet in Jun 2026.

Does Zimmer Biomet make free cash flow?

Yes. Operating cash flow minus capital spending was $1.52B in the last 12 months to Jun 2026.

How much cash does Zimmer Biomet return to shareholders?

$677.3M in buybacks and dividends in fiscal 2025, from the cash flow statement.

Zimmer Biomet buybacks and share count

Most people find these stocks after they triple. My readers find them before.

Free. Your email goes to Substack, which runs the newsletter. Privacy